Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

PURPOSE Promising results from new approaches such as radiosurgery or stereotactic surgery of brain metastases have recently been reported. Are these results due to the therapy alone or can the results be attributed in part to patient selection? An analysis of tumor/patient characteristics and treatment variables in previous Radiation Therapy Oncology Group (RTOG) brain metastases studies was considered necessary to fully evaluate the benefit of these new interventions. METHODS AND MATERIALS The database included 1200 patients from three consecutive RTOG trials conducted between 1979 and 1993, which tested several different dose fractionation schemes and radiation sensitizers. Using recursive partitioning analysis (RPA), a statistical methodology which creates a regression tree according to prognostic significance, eighteen pretreatment characteristics and three treatment-related variables were analyzed. RESULTS According to the RPA tree the best survival (median: 7.1 months) was observed in patients < 65 years of age with a Karnofsky Performance Status (KPS) of at least 70, and a controlled primary tumor with the brain the only site of metastases. The worst survival (median: 2.3 months) was seen in patients with a KPS less than 70. All other patients had relatively minor differences in observed survival, with a median of 4.2 months. CONCLUSIONS Based on this analysis, we suggest the following three classes: Class 1: patients with KPS > or = 70, < 65 years of age with controlled primary and no extracranial metastases; Class 3: KPS < 70; Class 2- all others. Using these classes or stages, new treatment techniques can be tested on homogeneous patient groups.

[1]  P. Grigsby,et al.  Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28. , 1993, International journal of radiation oncology, biology, physics.

[2]  L D Lunsford,et al.  A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. , 1994, International journal of radiation oncology, biology, physics.

[3]  G. Hommel A stagewise rejective multiple test procedure based on a modified Bonferroni test , 1988 .

[4]  I. Kaplan,et al.  Stereotaxic radiosurgery for brain metastases: the importance of adjuvant whole brain irradiation. , 1992, International journal of radiation oncology, biology, physics.

[5]  D. Nelson,et al.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.

[6]  G. Hommel A comparison of two modified Bonferroni procedures , 1989 .

[7]  T. Phillips,et al.  A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). , 1991, International journal of radiation oncology, biology, physics.

[8]  J R Adler,et al.  Stereotactic radiosurgical treatment of brain metastases. , 1992, Journal of neurosurgery.

[9]  R. Olshen,et al.  Tree-structured survival analysis. , 1985, Cancer treatment reports.

[10]  J. Crowley,et al.  Solitary Brain Metastasis: Results of an RTOG/SWOG Protocol Evaluation Surgery + RT versus RT Alone , 1990, American journal of clinical oncology.

[11]  R. Prentice,et al.  A qualitative discrepancy between censored data rank tests. , 1979, Biometrics.

[12]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[13]  H. Ford,et al.  The influence of extent and local management on the outcome of radiotherapy for brain metastases. , 1990, International journal of radiation oncology, biology, physics.

[14]  Ronald Brand,et al.  Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery , 1993, Annals of neurology.

[15]  D. Nelson,et al.  Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. , 1989, International journal of radiation oncology, biology, physics.

[16]  L. Deangelis,et al.  Primary cns lymphoma: Long-term results of an intensive combined modality therapy , 1994 .

[17]  J. O'fallon,et al.  Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients. , 1992, Journal of neurosurgery.

[18]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[19]  E. Noordijk,et al.  The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. , 1994, International journal of radiation oncology, biology, physics.

[20]  T. Phillips,et al.  Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. , 1995, International journal of radiation oncology, biology, physics.

[21]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[22]  R. Kaplan Supratentorial malignant gliomas: risk patterns and therapy. , 1993, Journal of the National Cancer Institute.